Literature DB >> 23439577

Fatigue heralding multiple sclerosis.

Joseph R Berger1, Jennifer Pocoski, Ronald Preblick, Susan Boklage.   

Abstract

BACKGROUND: Fatigue is a common symptom in multiple sclerosis (MS) and is an important determinant of overall well-being and disability.
OBJECTIVE: To assess the frequency with which fatigue precedes the diagnosis of MS using a retrospective database analysis.
METHODS: Between January 1, 2003 and September 30, 2008, patients diagnosed with fatigue with and without fatigue-related medications within a 3-year period prior to newly diagnosed MS were identified from the MarketScan Databases. All statistical analysis was performed using SAS.
RESULTS: Of the 16,976 patients with MS in the overall population, 5305 (31.3%) were newly diagnosed with MS and had three years of continuous healthcare coverage prior to MS diagnosis. Of these patients, 1534 (28.9%) were labeled with chronic fatigue syndrome (ICD9-780.71) or malaise or fatigue (ICD9-780.79) prior to the diagnosis of MS. One-third of these patients were labeled with fatigue one to two years before the diagnosis; 30.8% were diagnosed only with fatigue and had no other MS symptoms prior to their MS diagnosis. Among the patients diagnosed with fatigue, 10.4% were also prescribed medication for fatigue.
CONCLUSION: This study demonstrates that fatigue may herald MS, often by years. A careful history for transient neurological symptoms and a physical examination is warranted in any patient presenting with fatigue.

Entities:  

Keywords:  chronic; epidemiology; fatigue; fatigue syndrome; malaise; multiple sclerosis; quality of life

Mesh:

Year:  2013        PMID: 23439577     DOI: 10.1177/1352458513477924

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Corey Smith; Nanette L Douglas; Michelle A Neller; Katherine K Matthews; Leone Beagley; Sweera Rehan; Pauline Crooks; Tracey J Hopkins; Stefan Blum; Kerryn A Green; Zara A Ioannides; Andrew Swayne; Blake T Aftab; Kaye D Hooper; Scott R Burrows; Kate M Thompson; Alan Coulthard; Rajiv Khanna
Journal:  JCI Insight       Date:  2018-11-15

2.  Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.

Authors:  Kjetil Bjornevik; Kassandra L Munger; Marianna Cortese; Christian Barro; Brian C Healy; David W Niebuhr; Ann I Scher; Jens Kuhle; Alberto Ascherio
Journal:  JAMA Neurol       Date:  2020-01-01       Impact factor: 18.302

3.  Depressive symptoms and fatigue as predictors of objective-subjective discrepancies in cognitive function in multiple sclerosis.

Authors:  Abbey J Hughes; Jagriti Jackie Bhattarai; Samira Paul; Meghan Beier
Journal:  Mult Scler Relat Disord       Date:  2019-01-31       Impact factor: 4.339

Review 4.  Disease-Induced Skeletal Muscle Atrophy and Fatigue.

Authors:  Scott K Powers; Gordon S Lynch; Kate T Murphy; Michael B Reid; Inge Zijdewind
Journal:  Med Sci Sports Exerc       Date:  2016-11       Impact factor: 5.411

5.  Relationship Between Fatigability and Perceived Fatigue Measured Using the Neurological Fatigue Index in People with Multiple Sclerosis.

Authors:  Mayis Aldughmi; Jared Bruce; Catherine F Siengsukon
Journal:  Int J MS Care       Date:  2017 Sep-Oct

Review 6.  Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

Authors:  Michael P Pender; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2014-10-31

Review 7.  A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.

Authors:  Travis M Cruickshank; Alvaro R Reyes; Melanie R Ziman
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 8.  The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.

Authors:  Christian Veauthier; Helge Hasselmann; Stefan M Gold; Friedemann Paul
Journal:  EPMA J       Date:  2016-11-24       Impact factor: 6.543

9.  The relationship between fatigability and sleep quality in people with multiple sclerosis.

Authors:  Mayis Aldughmi; Jessie Huisinga; Sharon G Lynch; Catherine F Siengsukon
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-12-07

10.  The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study.

Authors:  Alia A Alghwiri; Fatima Jamali; Mayis Aldughmi; Hanan Khalil; Alham Al-Sharman; Dana Alhattab; Ali Al-Radaideh; Abdalla Awidi
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.